Skye Bioscience (SKYE) Accumulated Expenses (2012 - 2020)
Skye Bioscience (SKYE) recorded Accumulated Expenses of $81,813 in Q3 2020, up 116.9% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Accumulated Expenses (2012 - 2020) Analysis & Trends
At the end of FY2018, Skye Bioscience reported Accumulated Expenses of $118,248, down 17.8% from FY2017.
- Annual Accumulated Expenses has a five-year compound annual growth rate of -8.1% (FY2013 to FY2018).
- Across earlier years, Accumulated Expenses came in at $143,826 in FY2017 (+45.7%), $98,700 in FY2016 (-56.8%), $228,645 in FY2015 (+81.8%) and $125,799 in FY2014 (-30.1%).
- The Q3 2020 figure is the highest quarterly Accumulated Expenses since Q1 2019.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 126.0% in Q1 2017, against a decline of 77.8% in Q1 2018 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 81,813.00 |
| Jun 30, 2020 | 37,726.00 |
| Mar 31, 2020 | 35,645.00 |
| Mar 31, 2019 | 154,932.00 |
| Dec 31, 2018 | 118,248.00 |
| Sep 30, 2018 | 101,493.00 |
| Jun 30, 2018 | 60,524.00 |
| Mar 31, 2018 | 78,237.00 |
| Dec 31, 2017 | 143,826.00 |
| Sep 30, 2017 | 115,492.00 |
| Jun 30, 2017 | 201,110.00 |
| Mar 31, 2017 | 352,559.00 |
| Dec 31, 2016 | 98,700.00 |
| Sep 30, 2016 | 135,381.00 |
| Jun 30, 2016 | 166,740.00 |
| Mar 31, 2016 | 156,025.00 |
| Dec 31, 2015 | 228,645.00 |
| Sep 30, 2015 | 177,081.00 |
| Jun 30, 2015 | 177,537.00 |
| Mar 31, 2015 | 158,059.00 |
API Access
Skye Bioscience Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();